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Abstract
Practice Problem: An estimated 6.5 million American adults ≥20 years of age have heart failure
(HF) and worldwide 1 to 2% of the total healthcare budget is spent on HF. To improve outcomes
and streamline the treatment of HF patients, The American Heart Association (AHA) joined with
the American College of Cardiology (ACC) and created the Get With The Guidelines Program
(GWTG).
PICOT: The PICOT question that guided this project was in adult HF patients admitted to the
cardiovascular unit under the care of the hospitalist service, does implementing an evidence-based
practice (EBP) discharge medication protocol for physician use based on the AHA GWTG
program’s HF discharge medication protocol, compared to no standardized discharge protocol,
improve patients’ 30-day readmission rate, in 12 weeks?
Evidence: Evidence from 10 studies supported implementing an evidence-based GDMT tool into
a standardized HF discharge medication protocol for this project.
Intervention: Education and encouragement of use of the AHA GWTG discharge medication
protocol for HF in the electronic health record (EHR) was provided to a group of physicians on a
cardiovascular unit. The intervention was over a four-week period and pre- and post-intervention
protocol use was observed with specific measures analyzed for observation of improvement.
Outcome: The results determined there was minimal statistical significance, however, there was a
decrease in the financial measure of the cost of HF readmissions denoting a clinical significance.
Conclusion: Continued use of a guideline-based discharge medication protocol, such as the one
utilized in this project, is recommended based on the results and evidence provided in this project.
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Implementation of an Evidence-Based Practice Discharge Medication Protocol
for Heart Failure Patients to Reduce 30-Day Readmissions
Patients are diagnosed every day with heart failure (HF), a prominent form of heart
disease. Since HF is a complex syndrome, it requires a multidisciplinary approach to assist in
decision-making for each patient's treatment plan. To improve outcomes and streamline the
treatment of HF patients, The American Heart Association (AHA) joined with the American
College of Cardiology (ACC) and created the Get With The Guidelines Program (AHA, 2018).
The program is used by hospitals to improve heart disease patients' care by promoting consistent
adherence to the latest scientific treatment guidelines (AHA, 2018). This paper will evaluate the
effects of utilizing a guideline-based discharge medication protocol within the patient’s electronic
medical record (EMR) for the discharging provider.
This evidence-based practice (EBP) change was intended to improve the outcomes for HF
patients as an integral part of their comprehensive discharge plan. Utilizing a systems-level
approach to affect change in a healthcare organization may translate the knowledge that exists
supporting guideline-based HF management into standard discharge practice. Decreasing
variation at discharge for HF patients by implementing a standardized discharge protocol has been
associated with a better quality of care and decreased readmission rates (Basoor et al., 2013;
Smith et al., 2020). Hospitalization is an opportunity to optimize HF therapy because it gives the
physician a chance to consult with patients about the importance of adherence to HF medication
and of regular monitoring (Cowie et al., 2017). The DNP project’s goal is to implement the
discharge protocol to reduce 30-day readmission rates for HF-related causes.
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Significance of the Practice Problem
HF is a chronic, progressive condition in which the heart muscle cannot pump enough to
meet the body's blood and oxygen needs (AHA, 2017). An estimated 6.5 million American adults
≥20 years of age have HF (Benjamin et al., 2018 p. 7). The financial impact is enormous.
Worldwide, 1 to 2% of the total healthcare budget is spent on HF (Lesyuk et al., 2018, p. 1). It is
one of the most frequent causes of hospitalization and accounts for more than $30 billion of
United States (US) healthcare expenditure annually (Reddy & Borlaug, 2019).
The early post discharge period is a particularly high risk time that often leads to poor
outcomes (Smith et al., 2020). An average of 22.3% of HF patients are readmitted to the hospital
within 30 days at a mean cost of $14,631 per patient (Kilgore et al., 2017, pp. 65-66). At
discharge, patients are often prescribed numerous medications and must make drastic lifestyle
changes to improve their HF symptoms and outcomes. Also, there may be multiple comorbidities
to be managed alongside the diagnosis of HF (Albert & Kozinn, 2018).
The Affordable Care Act of 2010 recognized this as an essential issue (Affordable Care
Act, 2010). The legislation instituted a program to reduce the readmission rates of conditions such
as HF by penalizing providers for higher-than-average readmission rates. HF hospitalization is a
severe burden on healthcare, consuming significant healthcare resources, inflicting substantial
morbidity and mortality, and critically impacting the patient's quality of life (Cowie et al., 2017;
Yancy et al., 2018). It is prudent for healthcare organizations to seek the best options to increase
reimbursement for HF patients. These strategies must decrease the high cost for readmission and
provide the best outcomes for patients.
In the state of Florida, hospitalizations for HF among Medicare-eligible persons aged >65
years were 38, 347 in 2016 (CDC, 2016). In comparison, over 1,747 people in Duval County,
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Florida, were hospitalized in 2016 due to HF (Florida Department of Health, 2019). The hospital
setting for the Doctor of Nurse Practice (DNP) project has identified a significant issue with
increased readmissions of HF patients from 26.3% in 2019 to 28.2% in the first quarter of 2020
(D. Stiffler, personal communication, May 2020).
Currently, the organization where the EBP occurred has an "A" rating on the national
Leapfrog annual survey of healthcare providers (The Leapfrog Group, 2020). An area of
improvement identified as “well below the national average” is "communication about
medication" (The Leapfrog Group, 2020). Implementing the use of a structured discharge
medication protocol such as the AHA HF discharge medication protocol, in the EHR allowed
physicians to initiate, add, and adjust medications before discharge. This change was intended to
help patients achieve optimal therapy, reduce the chance of costly readmissions, and lead to better
quality outcomes. An associated physician-led conversation with patients at discharge about the
medication inclusion, combined with nursing’s reinforcement of the education at discharge sought
to improve the organization’s medication scores on the Leapfrog survey.
PICOT Question
The evidence-based intervention answered the following question: In adult HF patients
admitted to the cardiovascular unit under the care of the hospitalist service (P), does
implementing an EBP discharge medication protocol for physician use based on the AHA’s
GWTG program HF discharge medication protocol (I), compared to no standardized discharge
protocol (C), improve patients’ 30-day readmission rate (O), in twelve weeks (T)?
The patient population included in the EBP change project were adult inpatients at a forprofit hospital in Jacksonville, Florida, who were diagnosed with HF and admitted to the
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cardiovascular care unit. The patients included were under the medical care of the Team Health
Hospitalist group.
HF patients’ comprehension of discharge instructions is often inadequate (Regalbuto et al.,
2014). HF patients require clear guidance from both the physician and nurse on what medications
and instructions to follow when returning home. Providing useful discharge instructions, proper
dose up-titration, education about HF monitoring, and strict follow up decreases readmissions for
HF (Basoor et al., 2013). A protocol is a system of rules that explain the correct conduct and
procedures to be followed in formal situations (Merriam-Webster, 2020). Protocols include
guidance based on evidence from novel drug therapies, a treatment algorithm with more care
options, an updated approach to prevention, and essential updates regarding various forms of HF
and inpatient comorbidities (Fonarow, 2011; Yancy et al., 2018; Zamorano & Lozano, 2015).
The Center for Medicare and Medicaid Services (CMS, 2020) has developed a Hospital
Readmissions Reduction Program (HRRP). This Medicare value-based purchasing program
decreases payments to Inpatient Prospective Payment System (IPPS) at hospitals with excessive
readmissions (CMS, 2020). IPPS links payment to quality healthcare. Readmission for HF under
IPPS is an unplanned readmission within 30 days of discharge from the initial admission for HF,
and patients who are readmitted to the same hospital or to another applicable acute care hospital
for any reason (CMS, 2020).
Evidence-based Change Model and Change Theory
System-level practice change must be supported by a coalition of promoters who have
decided upon their goal, identified the known predictors of the goal, and aligned the strategies and
action steps accordingly to be sustainable (University of Texas, 2018). To form a coalition of
reinforcement, a nurse-driven system-level evidence-based change project must connect with a
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need of interest to gain physician involvement and adherence to project initiatives. Utilizing a
well-developed and trusted evidence-based change model will make the difference in planning,
implementing, and evaluating the project's intention.
The Iowa Model (see Figure 1, Appendix A) is an evidence-based model developed by
nurses, for nurses, to assist in incorporating successful strategies learned when undertaking
research utilization projects (Iowa Model Collaborative et al., 2017). The Iowa Model was chosen
because of its ease of use and focus on organizational-level change. The step-by-step
implementation process is clearly outlined. Leaders start by identifying a problem such as
increasing readmission rates of HF patients. They then investigate if this problem is a priority of
the organization to improve. This was done through confirmation by administrative leadership in
a formal letter. The project manager (PM) confirmed organizational interest and formed a team.
Stakeholders were identified through collaboration with the PM’s preceptor. The team included
the PM (student), preceptor, data analyst, hospitalist leader, cardiovascular nurse manager, and
former HF clinic nurse practitioner. A search for evidence to support the change process was
conducted (see Figure 2, Appendix A). The succeeding process was the designed appearance of
the change. The PM synthesized and appraised the evidence for the most beneficial strategy to
address the problem. The change was evaluated for appropriateness for the organization. The
intervention plan was discussed with the key stakeholders to assess their support of
implementation. The project results were presented to all stakeholders to encourage continued
support of the protocol usage throughout the organization. Employing a systematic approach to
integrating a discharge protocol into the routine of discharging HF patients will make the impact
of the EBP outcome on the patients and the health system easier to follow and to assess for
necessary changes. The project results were disseminated through a presentation to the key
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stakeholders, submitted to nursing journals for publication, and submitted to present at an EBP
nursing conference.
In addition to having an EBP model to follow for the structure of change, a leader should
understand change at the organizational level and have a theoretical basis to create a vision of
change for all to understand (Titler, 2008). Difficult times in healthcare call for interprofessional
collaboration to improve and sustain the best outcomes for safe and high-quality patient care
(Wojciechowski et al., 2016).
Lewin’s Three-Step Model for Change Management was selected as theoretical support
because it is used by nurses for quality improvement projects to transform care (Wojciechowski et
al., 2016). Lewin's theory proposed individuals and groups were influenced by restraining forces
or obstacles. These were aimed at keeping the status quo. However, Lewin noted driving forces
could be used as a positive push to cause change to happen (Lewin, 1951).
The three steps of the model were unfreezing, change, and refreezing (Lewin, 1951). The
discharge protocol implemented aimed to change the providers’ previous discharge process of
orders for HF patients. Engaging medical practitioners to “unfreeze” their current practice
requires strong influence and teamwork. These efforts may lessen the anxiety of the unknown to
diminish the restraining forces. Involving the nursing team and leadership to "drive" the change
and support the EBP project was intended to lead to the project's desired results. Finally, a
“refreezing” of the new norm can continue to benefit the healthcare teams’ professional practice,
improve patient health, and maximize future organizational outcomes for HF readmission rates.
Evidence Search Strategy
The search strategy used the University of St. Augustine (USA) Library’s databases:
CINAHL Complete, PubMed, Elsevier, ScienceDirect, Academic Search Index, and Pub Med.
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Reference indexing was also used to find reputable sources for support. The keywords used in the
USA search were "heart failure" and "guidelines" in the title and "readmission" in the subject
heading. The criteria peer-reviewed, English language, and publishing dates between 2010 and
2020 were used to refine the search. Inclusion criteria were: articles that utilized the GWTG
quality improvement program and those that used a checklist, protocol, or guideline-directed
therapy to reduce readmissions. Exclusion criteria removed articles that did not directly correlate
to the interventions, did not show evidence of reduced readmissions, or were duplicates. In the
search through PubMed, the MeSH headings used were "patient readmission," "patient
readmission/statistics," "numerical data," "heart failure," and "guidelines." The dates searched
were 2010-2020, and the same inclusion and exclusion criteria were applied. The reference lists of
studies included and systematic reviews identified in the search were carefully examined for
further eligible studies (see Figure 2, Appendix A).
Evidence Search Results and Evaluation
Studies concerning the successful implementation of a HF discharge protocol to reduce
readmissions proved to be challenging to obtain. Only 24 articles were found to support this EBP
project.
The rationale for inclusion was documented evidence of an improvement in HF patients'
readmission or of other outcomes based on similar interventions. Guideline-directed therapy and
protocols were also included as the proposed project's intent is to utilize direction from the
GWTG discharge protocol (see Figure 3, Appendix A). The results included studies that needed
to be generalizable to other HF discharge interventions, and medication optimization was a
primary factor to be considered. Articles were excluded if they did not involve HF patients that
were hospitalized and/or readmission outcomes.
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In the 10 articles selected and appraised, the overall level of evidence, based on the Johns
Hopkins Nursing Evidence-Based Practice Model and Guidelines (Dang & Dearholt, 2017), was
mostly Level II, then Level III, with one Level I (see Figure 1, Appendix B). The quality grade of
eight of the articles was a B, which is interpreted as good, reasonably consistent results, adequate
sample size and control, and relatively decisive conclusions. Two of the articles were found to be
a quality grade A, indicating the highest level of quality. The search strategy was limited due to
the availability of studies focused on reducing the readmission rate of HF patients by specifically
using a guideline-directed discharge protocol. Articles that did not have at least a quality grade of
B were not considered for inclusion. Four articles demonstrated Level III evidence, which can be
understood as having a well-designed study without randomization. Five articles were Level II,
and one article was a Level I. These criteria were felt to indicate the potential for positive results
if the project was accepted (see Appendix C).
Themes from the Evidence
The articles included as evidence for this project were born from studies completed in
various hospital settings and with many sample sizes. Participant hospitals in the studies may
have been enrolled in the GWTG-HF program or in a different guideline-directed HF
management program. Surveys, observational studies, core measure comparison, implementation
studies, and retrospective studies were some of the methods used to obtain data on HF patient
outcomes.
Themes from the evidence were examined as they directly related to the PICOT question
(see Appendix D). The most prevalent theme from the literature was the high level of variability
in how patients with HF have been prescribed treatment during their hospital stay and at discharge
(Basoor et al., 2013; Cutshall et al., 2018; Deschaseaux et al., 2016; Gilstrap et al., 2018;
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Heidenreich et al., 2014; Kociol et al., 2012; Yamaguchi et al., 2018). Discharge checklists were
used by some facilities (Basoor et al., 2013; Kociol et al., 2012) to enhance the healthcare team’s
ability to prescribe and order medications and to minimize the opportunity for missed guideline
recommendations. Medications commonly used as the standard treatment for patients with HF
with reduced ejection fraction (HFrEF) were beta-blockers (BB), neurohormonal agents, and
diuretics (Heidenreich et al., 2014; Wang et al., 2011; Yamaguchi et al., 2018). Some studies
found these medications were inconsistently prescribed (Cutshall et al., 2018; Gilstrap et al.,
2018; Heidenreich et al., 2014), not prescribed at all (Cutshall et al., 2018; Deschaseaux et al.,
2016; Gilstrap et al., 2018), and lacked the up-titration suggested by most HF guidelines (Basoor
et al., 2013). The patient population was determined to be at risk for hypotension due to the BB’s,
angiotensin converting enzyme inhibitors (ACE), or angiotensin II receptor blockers (ARB)
commonly prescribed for HF (Gilstrap et al., 2018). The risk could have contributed to the
hesitancy of patient adherence and of physician prescription in the studies. The irregular
prescribing practice may be related to the lack of substantial evidence, indicating a need for
guideline-directed medical therapy (GDMT) protocols to be implemented to assist in reducing HF
readmission rates.
Reducing readmission rates is a leading driver for healthcare organizations to employ
actions that help HF patients. Achieving the recommended <20% readmission rate directed by
most HF management programs has proven to be difficult (Bergethon et al., 2016). The studies
reviewed reinforced how problematic it was to prevent HF patients from demonstrating
worsening symptoms, which led to hospital readmissions (Cutshall et al., 2018; Gilstrap et al.,
2018; Kociol et al., 2012; Yamaguchi et al., 2018). Approximately 1 million hospitalizations a
year are related to HF (Deschaseaux et al., 2016). Demonstrating lower readmission rates for the
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HF patient population can lead to higher reimbursement rates and lower quality scoring for
hospitals (Gilstrap et al., 2018). The Basoor et al. (2013) study with the highest level of quality
evidence reported a significant reduction in 30-day and 6-month readmissions due to
implementing a guideline-directed discharge checklist similar to the protocol implemented in this
project. Other studies that focused on discharge intervention and GDMT did mention a decrease
in readmission rates as an indicator of accomplishment (Bergethon et al., 2016; Kociol et al.,
2012).
The literature review supported further investigation of quality improvement and systemslevel change initiatives utilizing evidence-based practices (Basoor et al., 2013; Deschaseaux et al.,
2016; Fonarow, 2011; Heidenreich et al., 2014; Kociol et al., 2012). Available evidence has been
synthesized to demonstrate the potential of an EBP change to reduce readmissions of HF patients.
This evidence supported implementing a discharge protocol using AHA’s GWTG
recommendations at discharge.
Practice Recommendations
Rather than relying on physician preference and level of HF diagnosis, HF patient
treatments should be individualized based on their specific needs and aligned with proven
therapies to reduce symptoms (Basoor et al., 2013; Bergethon et al., 2016; Cutshall et al., 2018;
Deschaseaux et al., 2016; Gilstrap et al., 2018; Heidenreich et al., 2014; Kociol et al., 2012;
Yamaguchi et al., 2018). The evidence supported a need to address the reduction of HF
readmissions in a systematic way. This was accomplished by implementing a discharge protocol
to standardize and guide physicians treatments based on evidence-based guidelines from AHA
recommendations (Basoor et al., 2013; Bergethon et al., 2016; Cutshall et al., 2018; Deschaseaux
et al., 2016; Fonarow, 2011; Gilstrap et al., 2018; Heidenreich et al., 2014; Kociol et al., 2012;
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Wang et al., 2011; Yamaguchi et al., 2018). It is common for HF patients to have comorbidities,
such as high blood pressure, renal disease, diabetes, and noncompliance issues. Gilstrap et al.
(2018) reported with Level II evidence the application of guidelines recommended for stable HF
populations was increasingly limited for hospitalized patients by hypotension, renal dysfunction,
and inotrope use, causing clinicians to frequently deviate from guideline use.
Three good to high-quality studies with Level I and Level II evidence reported an
association between GDMT with reduced readmissions (Basoor et al., 2013; Bergethon et al.,
2016; Kociol et al., 2012). However, Cutshall et al. (2018) indicated an increased length of stay
among the GDMT patients, which indirectly supported the DNP project. Five studies identified as
having good quality with Level II and Level III evidence identified a lack of consistent GDMT
among the HF inpatient population (Cutshall et al., 2018; Deschaseaux et al., 2016; Gilstrap et al.,
2018; Kociol et al., 2012; Yamaguchi et al., 2018). To change healthcare provider practice and
create a streamlined HF discharge plan, implementation strategies must be coupled with novel
guideline dissemination and organized physician engagement strategies such as the ones found in
the literature (Ellrodt et al., 2013).
Increases in all quality measures were observed over time among patients in settings that
consistently used the GWTG protocol. (Heidenreich et al., 2014; Kociol et al., 2012). Yamaguchi
et al. (2018) categorized participants into three groups and compared their 1-year mortality rate.
The results were: prescribed both an ACE-I/ARB (7.8%), either an ACE-I/ARB (19.6%), and
neither (34.4%). A study by Basoor et al. (2013) documenting checklist utilization was appraised
as having the highest level of evidence and highest quality grade. It supported the use of a
standardized discharge protocol, which reduced 30-day readmission rates from 20% to 2%.
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Strong evidence from the studies supported the feasibility of implementing an established
evidence-based GDMT tool (such as the AHA GWTG-HF discharge protocol) into a standardized
HF discharge medication protocol. The review further reinforced a need for urgent action to
reduce guideline nonadherence for this at-risk patient population. The GWTG discharge
medication protocol aimed to improve care quality while decreasing costs. Examples include
length of stay, readmissions, negative patient outcomes (Ellrodt et al., 2013; Fonarow et al., 2012;
Kociol et al., 2012; Yamaguchi et al., 2018).
Project Setting
The chosen facility for the project is part of an extensive for-profit healthcare system with
21 hospitals across the country and one in the United Kingdom. The hospital resides in an urban
setting with 454-bed capacity. It is competing with other sizeable acute care healthcare
organizations to be the leading healthcare provider in northeastern Florida and in its hospital
system division. The hospital’s mission mentions above all else, the organization is committed to
the care and improvement of human life. This organization's vision is to be an excellent place for
employees to work and an excellent place for physicians to practice medicine, resulting in an
excellent place for patients to receive care. The leadership is dedicated to finding innovative ways
to meet their community's healthcare needs, and both employees and leadership have a shared
vision to reach the highest levels of quality care.
The community served commands attention to HF, as it is an increasing issue for the
population (Florida Department of Health, 2018). The rise of HF 30-day readmissions from
26.3% in 2019 to 28.2% in the first quarter of 2020 is not easily explained by patient
demographics or behaviors but does offer an urgency to act (D. Stiffler, personal communication,
May 2020).
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The institution's organizational structure consists of an executive team under the authority
of the board of trustees. Despite being a small part of an extensive healthcare system, this hospital
has a strong sense of community and dedication of its staff to delivering a quality healthcare
product. The stakeholders in this hospital that have partnered with the PM were crucial to the
success and sustainability of the intervention (see Table 1 p.15).
Table 1.
Key Stakeholders

Support of the project was confirmed by a written agreement between the PM, preceptor,
and the Facility Medical Director of Hospital Services Department before implementation, and
approval for continued sustainability has been established by leadership and the medical team
since results have been shared. Sustainability was encouraged through the future use of a systemwide HF discharge protocol for practitioners. Compliance is intended to be enforced by the
cardiovascular and hospitalist leaders. The charge nurse on the cardiovascular unit where the
project was implemented is to continue recommending the discharge protocol upon daily
rounding with the physicians when a patient is identified as having a diagnosis of HF.
The level of interprofessional collaboration for this project was high. It required a
physician's commitment to participate, administrative-level approval, informatics support, nursing
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guidance and recognition, and financial backing to take each team member's time away from
current initiatives. This collaborative effort allowed participants to achieve together more than
they can individually, to serve a larger group of people, and to grow at individual and
organizational levels through systematic evidence-based change (Green & Johnson, 2015).
Strengths, opportunities, weaknesses, and threats were identified that may have affected
the project's planning, implementation, and execution phases (see Appendix F). The biggest
obstacle identified that the project faced was practitioner resistance to change due to high patient
volume and stressful working conditions exacerbated by the Covid-19 pandemic. The
organization was focused on staffing for optimal support of high-risk patients and on preventing
the spread of COVID-19. The intentions for the project were to highlight the need to address the
worsening issue of HF patient outcomes and take action with a proactive, evidence-based plan.
Project Overview
The DNP project's mission was "To provide HF patients a considerate, evidence-based
discharge medication regimen to reduce their chance of 30-day readmission”. The DNP project's
vision was "Purposeful reduction in HF patient complications through collaborative, guidelinebased efforts in patient care excellence." These statements directly align with the organization's
mission and vision as the patient is the focus for improvement.
The project's short-term objective was to implement a HF discharge protocol in the
hospital's cardiovascular unit. The long-term objective was to employ the continued use of a
sustainable system-wide HF discharge protocol to reduce 30-day HF readmissions. The risk of
such an ambitious goal is that HF patients are known for their multiple comorbidities and noncompliance due to strict medication regimens, diet, and self-monitoring (Sevinc & Samancioglu,
2017).
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The risk for unintended consequences was addressed by educating the Hospitalist’s group
prior to implementation that complicated HF patients’ discharge medication should be scrutinized
based on laboratory values identified in the GWTG-HF protocol and documented if
contraindications existed. If questions arise, then a conversation with the consulting cardiologist
was recommended per AHA guidelines.
Project Plan (Method)
A nurse's ability to turn evidence into practice can be difficult if they have not mastered
obtaining and appraising evidence. The Iowa Model (see Appendix A, Figure 1) guides clinical
decision-making for healthcare professionals and the EBP process from both the clinician and
systems perspectives (Iowa Model Collaborative et al., 2017). This model was chosen for this
project because of its ease of use and focus on organizational-level change. The Iowa Model also
offered a heuristic process for the investigator to gain a greater understanding of what kind of
change agent they may be in their future leadership role. The model’s use of a systematic
approach was helpful to this particular project as it was essential to determine the project’s impact
on the patients’ health and the system's outcomes. The following section is an outline of how the
model guided the EBP project.
Step 1: Identify Triggering Issues/Opportunities
The PM identified a need to address the increasing 30-day readmission rate for HF
patients at the specific facility. The issue of increasing HF readmissions at this specific facility
was highlighted in a quality measures report and shared with the division. Efforts have been made
to improve HF patient outcomes but have yet to produce positive results in this population.
According to Suter et al. (2014), 30-day readmissions are costly to healthcare organizations and
are likely to occur in one out of every four patients (p. 1333).
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Step 2: State the Question or Purpose
The project aimed to determine if "In HF patients, does implementing an EBP discharge
medication protocol for physician use, compared to no standardized discharge medication
protocol, improve patients’ 30-day readmission rate, in twelve weeks?”.
Step 3: Form a Team
The individuals identified as team members are not identical to the list of key
stakeholders. The selection of team members requires consideration of interprofessional
involvement, and of the skill sets required to plan, conduct, and evaluate the project (Iowa Model
Collaborative et al., 2017). The project's active phases of planning, implementation, evaluation,
and dissemination required a diverse set of skill sets and engagement in improving HF patients’
outcomes.
The PM has over 10 years of nursing leadership experience. The PM has worked with
many of the stakeholders for over 2 years and has established trust. The team was formed to
include the PM, preceptor, and data analyst.
Step 4: Assemble, Appraise and Synthesize Body of Evidence
It is imperative to appraise the entire body of evidence to gain sufficient knowledge of
potential barriers and successes (Dang & Dearholt, 2017). The John Hopkins Nursing EvidenceBased Practice Guidelines has assisted this phase (see Figure 1 Appendix B).
Step 5: Is there Sufficient Evidence?
This step can be seen as both subjective and objective depending upon the evaluator.
Weighing of the evidence involves incorporating multiple types of evidence as part of the initial
evidence review, evaluating evidence quality, quantity, and consistency (Iowa Model
Collaborative et al., 2017). There is sufficient supportive evidence for utilizing AHA's GWTG HF
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protocol in reducing 30-day readmission rates (Bergethon et al., 2016; Kociol et al., 2012; Wang
et al., 2011). There is high-quality evidence backing the GDMT in reducing 30-day readmission
rates and outcomes for HF patients (Basoor et al., 2013; Fonarow et al., 2012). There is abundant
evidence highlighting the need for consistent GDMT at discharge for HF patients (Cutshall et al.,
2018; Deschaseaux et al., 2016; Fonarow et al., 2012; Gilstrap et al., 2018; Heidenreich et al.,
2014; Wang et al., 2011). The PICOT question was supported by the evidence.
Step 6: Design the Practice Change
An interview with the key stakeholders about the plausibility and support for the initiative
provided insight into the project design. A practice change was created that did not lead to staff
rebellion. Organizational infrastructure and the commitment of resources was assessed throughout
the project. It was important to identify all the possible gaps that needed to be filled before
implementation (Iowa Model Collaborative et al., 2017).
Step 7: Is Change Appropriate for Adoption in Practice?
The judgment of whether or not the project was appropriate for practice was dependent on
many factors including the results of the statistical analyses, clinical significance, and the practice
change’s effect on the unit’s culture. A consistent feedback loop between the PM, physicians, data
analyst, and key stakeholders was enforced. The results of the project were summarized and
disseminated to select members of the organization for a potential future system-wide
implementation.
Step 8: Integrate and Sustain the Practice Change
The integration of change requires ongoing engagement of the team members after the
project is completed with continuous evaluation of key performance indicators. In this project, the
Hospitalist Group buy-in was significant to the results of the practice change. The charge nurse on
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the cardiovascular unit was encouraged to educate and remind the rounding practitioner to use the
discharge protocol. A continuance of use of the protocol was recommended, and practitioners
were educated on its benefits and use requirements.
Step 9: Disseminate the Results
Results were disseminated to key stakeholders and team members. The information
presented to key stakeholders was in a formal format at the Executive Cardiovascular Committee
meeting and sent in a Power Point presentation to all key stakeholders. The project manager will
pursue publication for this project.
The planning, initial data collection, and submission for approval was completed within
four weeks of the project's implementation and the remainder of the data collection occurring
throughout the implementation phase and 30 days post to capture any readmissions (see Table
A1). Analysis and measurement of data was necessary after the last phase and continued until
interpretation of the results were clear.
The project budget included the cost of wages for the utilization of team members' time to
assist in the collection and organization of data. The discharge protocol was embedded in the
organization's EHR, so there was no cost for customization of the EHR. There was minimal cost
to the organization (see Table A3).
The timeline of the project was broken into three phases and extends from identification of
the practice problem until dissemination of the evidence. The first phase was where the problem
was identified, the organization was evaluated for readiness for an EBP change project, evidence
was found to support an EBP change, and a plan was created for the project. The second phase
consisted of organizational approval for the intended EBP change, IRB approval, stakeholder
engagement, and implementation. The PM used a 4-week timeframe for implementation. The
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final phase included data collection, data evaluation, evaluation of plan for sustainability, and
dissemination of the findings. All three phases concluded April of 2021. (see Appendix E).
Results
The following section describes the data collection, evaluation, analysis, and the
interpretation for significance.
Data Collection and Analysis
Data collection and review occurred retrospectively for 4 weeks prior to and 4 weeks after
implementation of the AHA GWTG-HF protocol; 30-day readmission rates were assessed post
intervention. Baseline measurements were collected using chart audits of all HF diagnosed
patients in the cardiovascular unit under the Team Health hospitalists’ care and were compared to
data collected throughout the implementation phase. All HF admissions were documented 30days post-intervention to capture patient readmissions. In all project phases, data were collected to
evaluate the outcomes of improvement in the 30-day readmission HF patient readmission rate and
protocol usage (see Table A1). Necessary data was transferred to an Intellectus software
spreadsheet for analysis (see Table A2).
Recruitment, Selection of Participants and Approvals
Inclusion criteria were specific to project dates and included adult patients between 18 and
100 years of age, similar to AHA GWTG HF guideline inclusion criteria. Patients were included
if they were admitted to the cardiovascular unit, under the Team Health hospitalist care, and had a
HF diagnosis. Patients were excluded if they were upgraded to another unit, discharged by a
physician other than a hospitalist, admitted to hospice service, or deceased. The medical record
number identified the patients. No personal identification information was collected.
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The approval process for the USAHS Evidence-based Practice Review Council (EPRC)
included submitting endorsements received from the facility where the project was to be
implemented and authorization of use for the Iowa Model and the AHA-GWTG discharge
protocol. The Team Health Hospitalist leader and the Cardiovascular Service Line Administrator
gave written project approval.
Participants in Data Collection and Analysis
The PM collected patient information from the EHR. The analyst responsible for entering
data into other cardiac registries collected specific daily reports from the quality department. The
reports identified all patients admitted and coded with a diagnosis of HF in the specified date
range. Reports were provided to the PM weekly.
Data Storage and Misplacement
Spreadsheet programs are valuable tools for entering, organizing, and storing data
(Broman & Woo, 2018). Non-specific patient data was stored in the PM’s personal computer
within an Excel spreadsheet and Intellectus software. The PM was the only team member with
access to the data to ensure process integrity. Daily patient reports were returned to the analyst
after data extraction for disposal. The PM reviewed all patients admitted during the
implementation phase to ensure no HF patients were omitted. No missing data was found.
Integrity of the Data
The PM validated data integrity of daily reports weekly by applying current methods to
identify HF hospital patients through the Meditech EHR.
Evaluation Design, Tools, and Type of Data
The project used a pre- and post-design to evaluate the impact of the intervention
(Stratton, 2019). Primary data examined included a mixture of continuous and discrete variables
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presented as standard deviations, frequencies, means, and percentages (Giuliano & Polanowicz,
2008). Descriptive data were nominal, ordinal, and continuous (Marshall & Jonker, 2010).
Variables were analyzed using descriptive, comparison, and non-parametric statistics.
Categories of Measure
The outcome measure was the 30-day readmission rate for HF patients both pre, post, and
for 30 days after the end of the implementation phase (Stratton, 2019). Balancing, process,
financial, and sustainability measures were analyzed. Benchmarks were recorded based on preintervention data (see Appendix G).
Data Analysis
Descriptive statistics, paired t-tests, and chi-square tests were used to analyze the data
(Vetter & Mascha, 2018). “N” indicated the patient was not readmitted and “Y” indicated the
patient was readmitted (see Appendix H, Table 1). Results of the Chi-square test were not
statistically significant based on an alpha value of 0.05, χ2(2) = 1.11, p = 0.573. These suggested
the primary outcome measure (30-day readmission) and phase were independent of one another
(Intellectus Statistics, 2019). This further implied the observed frequencies were not significantly
different than the anticipated frequencies. None of the data in the 30-day intervals met the target
of at least a 20 percent reduction of the 30-day readmission rate (see Table H2)
The process measure of HF discharge protocol utilization was analyzed using a two-tailed
paired samples t-test (Intellectus Statistics, 2019). The result was statistically significant based on
an alpha value of 0.05, t (12) = -6.68, p < .001, indicating the null hypothesis could be rejected
(see Appendix H, Table 3 and Figure 1). Descriptive analysis of the number of times the protocol
was used indicated an average of 1.46 (SD = 1.71, SEM = 0.48, Min = 0.00, Max = 6.00,
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Skewness = 1.41, Kurtosis = 1.75). The target of 95% usage in each week was never reached (see
Table H4).
An insufficient number of observations was identified when performing descriptive
statistics on the balancing measure of number of HF patients identified. Frequencies and
percentages were calculated (Intellectus Statistics, 2019). “N” indicated the protocol was not
mentioned to the rounding physician, and “Y” indicated the protocol was mentioned (see Table
H5). No data was collected during the fifth 2-week period as it was post-intervention assessment
time.
The financial measure was analyzed using the mean cost of readmission per patient of
$14,631 (see Table H6). These percentage reductions surpassed the target of 20% per 30-day
period. Sustainability of the use of the protocol 30-days after the intervention period (Trimester 3)
was measured using frequencies and percentages. “N” represented the protocol not being used
(see Figure H2). The target goal of at least 95% usage was not met.
Statistical and Clinically Significant Results
The only test that produced a statistically significant result was the two-tailed paired
samples t-test for the process measure (Intellectus Statistics, 2019). This indicated the null
hypothesis could be rejected. The outcome of the p value must be less than 5% for the
intervention to be deemed statistically significant (Andrade, 2019). The p value was >0.001.
Considering the small sample size in the last two phases, clinical significance can be
partially assumed. With reminders to physicians, there was a 40% increase in use of the protocol.
This indicated the importance of communication between the nurse and physician to improve HF
management at discharge. Unfortunately, after the intervention phase, there was a 37% decrease
in protocol usage. The 30-day readmission rate did not meet the goal of a 20% reduction from the
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benchmark measure; however, it did result in a 10% reduction comparing pre-intervention 30-day
readmission rates to the last 30 days observed. Overall, this can be seen as an improvement in the
outcome measure.
The most obvious clinically significant finding was the financial measure. The decrease in
cost of readmissions for each 90-day period was 30% and 29% respectively, which exceeded the
project’s goal of 20% decrease. This may represent an attractive amount of savings for the
hospital and support continued protocol use.
Formative and Summative Criteria
The GWTG registry collects achievement and quality data from organizations that
participate in their program (AHA, 2020). This includes, but is not limited to, prescribing of ACE,
ARB, aldosterone antagonist (AA), and evidence-based specific BB at discharge. The PM
collected these formative results in the pre- and post-intervention phases and will share the data
with key stakeholders. Summative criteria were results of benchmarking measures.
Extraneous Variables
The PM controlled for extraneous variables by using only a single inpatient unit, patients
discharged from the hospitalist group, and data needed for evaluation. This reduced the number of
participants for data collection.
Protection of Human Subjects
Patient data were not collected until approval was received from the EPRC of USAHS.
This ensured the ethical safety of the project. The hospital where the project was implemented did
not have an IRB.
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Impact
HF is a problem not easily solved. The facility previously identified the value of the
evidence-based medication guidelines by having the recommended protocol medications
embedded into each patient discharge summary. This made a smooth transition for the PM to
reinforce its use. Hardwiring a new practice for this facility’s Team Health Hospitalists group was
not as smooth.
Before the project, the PM identified through data collection that usage of the existing tool
was minimal (see Table H4). Her efforts to encourage protocol usage were not impactful enough
sustain increased use of the HF protocol. Physician noncompliance during the intervention phase
was discussed with their leadership. After formal presentation of results, there was discussion
amongst the medical team that supported future protocol use.
Review of the 30-day readmission rate indicated no statistically significant difference
associated with the intervention. However, there was a decrease in the actual readmission rate
from pre to post intervention (see Table H1). Reducing hospital readmissions for HF patients is a
national priority, and quality improvement efforts are targeting reductions of ≥20% (Bergethon et
al., 2016). This project documented a trend of high HF patient readmission rates at this facility.
None of the project phases ever reached a 30-day readmission rate lower than 26% (see Table
H1). However, the literature supported that consistent use of the discharge medication protocol
will lead to a decreased 30-day readmission rates in HF (Basoor et al., 2013; Kociol et al., 2012).
Future Implications
The reduction in the readmission cost to the facility between each 30-day period was
never less than 29% (see Table H6), and this represented a significant savings for the hospital. If
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the HF discharge medication protocol occurred at the enterprise-level, then the cost savings would
be substantial.
The PM’s preceptor stated since the conclusion of the EBP project that the organization is
beginning to present a quality improvement initiative on the selection of the AHA-GWTG HF
medications that directly relates to reimbursement objectives. Upon discharge, HF patients must
have each one of the categories of medication (ACE/ARB/ARNI, BB, and AA) selected by
physicians, which aligns with this project’s specific goals. Combining reimbursement reduction
with an organizational drive for guideline adherence will assist in optimizing the reduction of 30day readmission rates for HF patients. The presentation of this project’s results reminded the
stakeholders of the evidence supporting the intervention and provided a potential structure for
strategic efforts to improve HF patient outcomes.
Limitations
Limitations that occurred during the EBP project are as follows: First, there was a limited
area of surveillance (1 inpatient unit). Had the project involved several units, or the entire
population of HF patients, the number of observations would have been more significant. The
facility may consider employing the recommended practice change to all HF patient discharges to
evaluate for a more significant reduction in readmissions.
Secondly, the time of the project’s intervention was interrupted by a global pandemic of
COVID-19. The priority of the hospital administration and staff revolved around controlling the
spread of infection due to COVID-19, and caring for those affected with the illness. New
initiatives were secondary to managing this novel virus with an already limited supply of staffing.
Recently, the numbers of hospitalized patients with COVID-19 have decreased and the facility is
back to focusing on other priorities. Since dissemination of results, the continuation of GDMT
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with the GWTG-HF discharge protocol may become an organizational focus leading to
sustainability of the change. Support for this continued initiative is relevant due to GDMT for HF
becoming a recent topic of discussion in recent cardiovascular committee meetings.
Thirdly, the evidence of poor utilization of GDMT by the facility physicians prior to the
initiation of the change represents another limitation. A history of inadequate adherence to
practice standards with limited oversight and accountability is contradictory to a sustainable
practice change. This is an issue leadership may address as the results of this project represent a
failure of compliance with recommended guidelines and insubordination. Further study of
physician engagement in protocol utilization is needed to identify if a statistical significance truly
exists between the protocol and the 30-day readmission rate.
The holiday season being concurrent with the implementation phase may have affected the
results. Difficulty adhering to a restricted diet during the holidays and not wanting to be in the
hospital during the holiday season may be related to the results. The high readmission rate that
continued throughout the project phases may have been due to the “holiday effect” some HF
patients experience (Reedman et al., 2008).
Finally, the PM not being employed where the project was implemented was found to be a
significant limitation. If the PM worked at the facility there would have been daily observance
and encouragement of the protocol with both the physicians and nursing staff. Established
relationships can assist in buy-in and a deeper engagement of stakeholders (Rycroft-Malone et al.,
2016).
The limitations identified may have affected the statistical significance of the project
results but did not affect the importance of the practice problem of HF readmissions. The project
has highlighted the availability of a tool within their EHR that discharging practitioners can use to
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better manage HF patient outcomes while not drastically altering their current practice.
Discharging a HF patient can be standardized with this GDMT, with the exception of individual
identified exclusionary criteria.
Plans for Dissemination
The results of this evidence-based practice change project will be shared both internally
and externally of the organization. All team members will receive a presentation with PowerPoint
slides emailed to them. The Cardiovascular Executive Committee was presented with a face-toface explanation and presentation of results at the March meeting, facilitated by the PM’s
preceptor. This internal dissemination will be done to enhance awareness, create a clear
understanding of the intervention’s benefits to the organization, identify areas of improvement in
addressing the practice problem, and help motivate the organization to sustain the EBP change.
The external dissemination of results will be sought through two nursing publications, one
supported by the American Nurses Association (ANA) and the other supported by the AHA.
First, the Online Journal of Issues in Nursing (OJIN) is described as “an online publication that
reaches nursing professionals around the world” (American Nurses Association, 2020 ). This
monthly, peer-reviewed journal, enhances comprehensive knowledge of topics relevant to nursing
and helps build up a shared knowledge base (American Nurses Association, n.d.).
The second nursing publication that will be considered for submission is the American
Journal of Nursing (AJN). The AJN reaches more nurses than any other nursing journal through
powerful print, website, institution, and social media channels (Lippincott Williams &
Wilkins.org, 2020). It is viewed in Ovid, the institutional platform used by health systems and
libraries. This is significant because all healthcare personnel can have access to the information
provided by the project.
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This scholarly work will also be submitted to The University of St. Augustine’s
institutional repository called SOAR@USA. This is an opportunity for the project manager to
display the completed work to the public alongside other works from the university’s students,
faculty and alumni.
The opportunity to present at conferences will be sought at the state and national level.
Locally, the Florida Nurses Association hosts an annual Nursing Research and EBP Conference
that would be the appropriate forum for the dissemination of findings. On a national scale, the
American Nurses Credentialing Center hosts a virtual summit. This includes nurses from around
the country who are provided the forum to present their work via the internet to empower
professionalism and continued knowledge growth without having to travel. The flexibility and
convenience of this virtual option allows for a broader audience to be reached while adhering to
the current social distancing requirements.
Conclusion
HF’s burden affects healthcare organizations on many levels. The impetus for this EBP
change project is the failure of the organizational efforts to reduce 30-day readmission rates for
their HF patient population. Conformity with quality measures such as the AHA’s GWTH-HF
discharge medication protocol has shown improvements with clinical outcomes (Fonarow, 2011).
The problem has been identified and sufficient evidence has been found to support the
intervention planned. Organizational readiness will be further assessed to establish a supportive
environment for the systems-based EBP change. Forming a team of motivated system-wide
interdisciplinary professionals will be essential. Standardization of HF patient discharge
medications using a guideline-directed protocol, as detailed in the steps of this project, can be the
needed change to address the costly cycle of a HF patients’ disease in all healthcare organizations.
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Table A3.
Budget
EXPENSES

REVENUE

Direct

Institutional budget support

Salary and benefits of staff for
meetings.
Approx. 6 hrs of meetings
• Key stakeholders (see Table 1.)
4hrs/avg hourly pay $60
• 5 CVU charge nurses 2hrs/avg
hourly pay $37
• Data analyst 12hrs/avg hourly
pay $35
Total Expenses
Net Balance

$3670

$2880
$370
$420
$3670 Total Revenue
$0

$3670

IMPLEMENTATION OF DISCHARGE PROTOCOL
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Figure A1.
The Iowa Model Revised

Note. Iowa flow chart diagram from “Iowa Model of Evidence-Based Practice.” Iowa Model Collaborative. (2017).
Iowa model of evidence-based practice: Revisions and validation. Worldviews on Evidence-Based Nursing,
14(3), 175-182. Doi:10.1111/wvn.12223. Copyright 2015 by University of Iowa Hospitals and Clinics.
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Figure A2.

Identification

PRISMA Diagram
Records identified through advanced search of University

Additional records identified through

of St. Augustine for Health Sciences database searching

other sources such as reference

heart failure, guidelines, readmission

searches

(n = 24)

(n = 4)

Screening

Records after duplicates removed
(n =26)

Records screened
Records excluded

(n = 26)

Eligibility

(n =16)

Full-text articles assessed for eligibility
Full-text articles excluded, with reasons
(n =10)
(n =0)

Studies included in qualitative synthesis

Included

(n =10)

Studies included in quantitative synthesis (meta-analysis)
(n =10)

Note. Prisma flow chart diagram from “Preferred Reporting Items for Systematic
Reviews and Meta-analyses: The PRISMA Statement,” by D. Moher, A. Liberati, J.
Tetzlaff, & D. G. Altman, 2009, Annals of Internal Medicine, 151(4), p. 267
(http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00135). Copyright 2009 by The
American College of Physicians.
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Figure A3.
Get With The Guidelines: Target HF Discharge Checklist

American Heart Association. (n.d.). Target heart failure: Heart failure discharge checklist. American Heart Association.
https://www.heart.org/-/media/files/professional/quality-improvement/target-heart-failure/targethf-dischargechecklist-ucm_496869.pdf?la=en
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Appendix B
Figure 1
John Hopkin’s Evidence Level and Quality Guide
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Institute for Johns Hopkins Nursing. (n.d.). JHNEBP model and tools-permission. Johns Hopkins Nursing.
https://www.ijhneducation.org/node/18409/done?sid=71039&token=3dd2085cfcf2ba222ffa8d34b0e21506
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Appendix C
Table 1
Summary of Primary Research Evidence
Citation

Quality
Grade

Question

Search
Strategy

Inclusion/
Exclusion Criteria

Data Extraction and
Analysis

Key Findings

Usefulness/Recommendation/
Implications

Kociol et al.,
2012.

Level II
Grade B

Surveying
patients whose
hospital
participates in the
Get With the
Guidelines-Heart
Failure quality
improvement
program, What
are the common
processes of care
aimed at
reducing
readmissions?

None

100 randomly selected
hospitals participating
in GWTG. Patients
were eligible for
inclusion in the registry
if they were admitted
to a hospital for an
episode of worsening
heart failure or
developed significant
heart failure symptoms
during a hospitalization
for which heart failure
was the primary
discharge diagnosis.

Used a telephone survey
developed for this study
and administered the
survey to personnel at
randomly selected
hospitals participating in
the GWTG-HF quality
improvement initiative.
We present hospital
characteristics by
readmission quartile,
using means with SDs for
continuous variables and
frequencies with
percentages for
categorical variables.
Assessed associations
between quartiles and all
variables using CochranMantel-Haenszel nonzero
correlation tests. Scored
in each domain overall
and by readmission
quartile. Assessed
associations between
domain scores and
readmission quartiles
using Cochran-MantelHaenszel nonzero
correlation tests. Tested
for associations between
domain scores and
continuous riskstandardized readmission
rate.

Modest association
between more
complete discharge
and transitional care
processes and lower
30-day readmission
rates (Kociol et al.,
2012)

The use of computerized reminders
and discharge checklists was used in
<50% of the sites surveyed.
Computerized discharge instructions
or pop-up reminders to prescribe
evidence-based therapies were only
used by 24% and 18% of hospitals,
respectively (Kociol et al., 2012). This
shows a lack in use of tools provided
by GWTG, and need for further
studies based on the effectiveness of
checklists and guideline-based
prescribing.
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Gilstrap et
al., 2018.

Level II
Grade B

What is the
frequency and
reasons for
noncompliance
with heart failure
(HF) guidelines
at the time of
hospital
discharge from
both academic
and community
hospitals?

None

All patients admitted to
the HF services of
either hospital during
the study period with a
primary diagnosis of
HF were considered for
inclusion. Exclusion
criteria included new‐
onset HF, end‐stage
renal disease requiring
hemodialysis, or end‐
stage HF requiring
palliative care. Patients
admitted for
consideration of
advanced therapies,
including mechanical
circulatory support or
transplantation, were
also excluded.

Data collection methods
not shared. Descriptive
statistics are reported with
frequencies, percentages,
means (for normally
distributed data), and
medians (for non‐normal
data) with between‐
sample comparisons
conducted using standard
parametric or
nonparametric tests, as
appropriate. Fisher exact
and χ2 tests were used to
compare changes in
congestion status,
perfusion status,
neurohormonal dosing,
and readmission rates
between groups.
Statistical analyses were
conducted using SAS v9.3
(SAS Institute).

Bergethon et
al., 2016.

Level III
Grade B

What are the
trends in 30-day,
all-cause
readmission rates
from 2009 to
2012 among
patients with
heart failure and
what are the care
processes and
hospital factors
associated with
the trends?

None

Patients were included
if they were discharged
on or before November
1 of each calendar
year. Patients were
excluded from the
analysis if they were
ineligible for fee-forservice Medicare at the
time of discharge from
the index
hospitalization, they
died in hospital, their
discharge status was
missing or not

Combined data from the
GWTG-HF registry, the
American Hospital
Association Survey on
Hospital Characteristics,
the Dartmouth Atlas of
Healthcare, CMS
administrative claims, and
the CMS Hospital
Compare data.
Presented categorical
variables as frequencies
and percentages and
continuous variables as
means with SDs, medians,

Among all HF
discharges, 25%
were done with
residual congestion
Among discharges
of patients with HR
with reduced
ejection fraction,
37% were
discharged on less β‐
blocker and 46%
were discharged on
less angiotensin‐
converting enzyme
inhibitor or
angiotensin II
receptor blocker
compared with
admission.
Renal dysfunction
was the most
common reason for
discharge with
residual congestion,
and hypotension was
the most common
reason for discharge
with no or decreased
neurohormonal
therapy. Recent
inotropic use was
also commonly cited
at the academic
hospital.
Several hospital
factors were
associated with
relative rates of
readmission, with
structural factors,
particularly teaching
hospital status,
likely contributing
the most to
readmission rates as
opposed to
modifiable care
delivery factors.

Clinicians frequently deviate from
guidelines at both academic and
community hospitals. However, this
may not always indicate poor‐quality
care. Application of traditional HF
guidelines, which were developed in
stable HF populations, at the time of
hospital discharge is increasingly
limited by hypotension, renal
dysfunction, and recent inotrope use in
more tenuous HF patients. Patients
with renal dysfunction, hypotension,
and recent inotrope use merit further
study to determine best practices and
possibly to adjust quality metrics for
HF severity.

There has been slight improvement in
30-day all-cause readmission rates in
patients with heart failure, few
hospitals have seen large success.
More research is needed to understand
how to improve hospital readmission
for patients with heart failure
regarding how to identify and
implement best practices nationally.
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documented, they left
against medical advice,
or they were
transferred to an acute
care facility. Hospitals
were excluded if they
had fewer than 10
patients in GWTG-HF
program in 2009 or
2012.

Wang et al.,
2011.

Level II
Grade B

To what degree is
hospital
performance for
acute myocardial
infarction (AMI)
and heart failure
(HF) care
processes
correlated?

None

Compared hospital
performance of the
Centers for Medicare
& Medicaid Services
AMI and HF core
measures in 283
hospitals submitting 10
or more patients to the
Get With The
Guidelines AMI and
HF programs between
January 2005 and April
2009.

and interquartile ranges.
Compared categorical
variables using Fisher
exact test. Compared
continuous variables
using Kruskal–Wallis
tests. Evaluated the
relationship between
baseline readmission rates
and relative rate reduction
by calculating relative
change in 30-day riskadjusted readmission rates
between 2009 and 2012 as
a function of quartiles of
2009 risk-adjusted
readmission rates using a
Kruskal–Wallis test.
Determined trends across
admission years using an
unadjusted linear
regression model with
generalized estimating
equation to account for inhospital clustering, with
percent readmission as the
outcome and admission
year as the explanatory
variable. Performed a
sensitivity analysis
designed to ensure that
our study population had
similar rates of relative
change in readmissions to
hospitals nationwide.
Data were collected via a
web-based patient
management tool that
provides decision support
with real-time online
reporting features.
Descriptive statistics were
used to characterize
hospital-level
performance of AMI and
HF core measures. The
correlation between
hospital performance in
AMI measures and

Found only a modest
correlation between
a hospital’s
performance in AMI
measures compared
with its performance
in HF measures.
However, centers
that excel at both
AMI and HF
measures have better
performance than
centers that excel at
neither or at each

Refining of quality improvement
strategies is needed to optimize the
consistency of hospital quality of
cardiovascular care. Assessments of
hospital performance may be aligned
better with the overall quality of
inpatient cardiovascular care, rather
than the delivery of care within a
specific therapeutic area.
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Heidenreich
et al., 2014.

Level III
Grade B

What is the
impact of the
Plus Awards on
overall quality of
heart failure care
for hospitals
participating in
the GWTG‐HF
program?

Cutshall et
al., 2018.

Level II
Grade B

How effective is
the treatment of
HfrEF and its
outcomes in
patients with
ESRD requiring
dialysis in the
inpatient setting?

None

None

Identified all patients
hospitalized with heart
failure from 2008
through September
2011. Excluded
patients without
laboratory data
reported and those
from hospitals that did
not report medical
history data routinely,
patients who died
during hospitalization,
and those who were
transferred to another
healthcare or acute care
facility or who left
against medical advice.

Patients were identified
through the corporate
patient financial
services
database using ICD-9CM code 586.6 for
ESRD and
ICD-9-CM codes for
HfrEF. Patients were
included if
they were at least 18
years of age, had a
diagnosis of
ESRD requiring
hemodialysis (HD) or
peritoneal dialysis
(PD), had a diagnosis
of HfrEF or had a
documented

hospital performance in
HF measures was
determined using
Spearman correlation
coefficients.
Patient and hospital
characteristics,
achievement, and quality
measures were
summarized descriptively
for the preprogram and
program periods. P values
were based on Pearson
chi‐square tests or
Wilcoxon tests. Logistic
regression was used to
assess the relationship
between increasing
calendar time in months
and odds of outcome. A
secondary analysis
examined differences in
use of the 9-quality
metrics between Plus
Awards and non‐Plus
Awards hospitals.
Analyses were performed
using SAS software
(version 9.2; SAS
Institute).
Patient demographics and
comorbidities were
collected for all patients.
Any HF med that was
administered to a patient
while hospitalized, as
documented in the
electronic medication
administration
record, was collected to
determine if patients
continued
or initiated HF
medications during
hospitalization.
Discharge medications
were also collected from
the discharge summary to
determine whether

alone, and these
centers have
significantly better
patient outcomes.
The study did not
show that use of
recommended
treatments uniformly
accelerated
following onset of
the program. There
was continued
improvement in the
achievement
measures with no
erosion in
performance on any
of these key metrics.
Observed uptake of
some targeted
therapies
accelerating after
recognition (ICD
use) and others
decelerating
(vaccinations).

Increases in all quality measures were
observed over time; however, the use
of several treatments remained low,
including use of hydralazine–nitrate
combination for patients of African
descent and aldosterone antagonists in
appropriate candidates. Given the
underlying societal trends toward
increasing use of most guideline‐
recommended therapies, it is important
to examine the change in rate of
increase with any intervention
designed to improve care.

The study did not
show improved
short-term
outcomes, the
decrease of LOS in
the GDMT Current
guidelines
recommend standard
therapy for patients
with HfrEF and
ESRD these
guidelines are not
routinely being
followed.

Investigations need to be made into
why ESRD and HfrEF patients are not
receiving GDMT.
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Yamaguchi
et al., 2018.

Level II
Grade B

What is the status
of GDMT at the
time of discharge
in patients
hospitalized with
acute HF and to
evaluate its
association with
all-cause
mortality and HF
readmission,
using real-world
multicenter
prospective
registry data?

None

ejection fraction of
40% within a year prior
to admission, and had a
hospital
length of stay (LOS) of
at least 3 days. Patients
were
excluded if they were
admitted directly to an
intensive
care unit, were
pregnant, had a history
of kidney
transplant, or were
diagnosed with ESRD
within 3
months of admission.
1,682 consecutive
patients hospitalized
with acute HF were
prospectively
registered from 20
hospitals in Japan.
Excluded 13 patients
with in-hospital death
and nine patients with
missing data on GDMT
at discharge.

patients were prescribed
HF therapy at discharge.
Statistical tests used to
analyze baseline
characteristics and study
outcomes were the chi
square, Fisher’s
exact test or MannWhitney U test where
appropriate, by
means of the Minitab
statistical software.

All consecutive patients
aged ≥ 20 years old with a
primary diagnosis of acute
HF hospitalized through
the emergency department
at participating hospitals
were enrolled upon the
initial hospital admission
and were followed-up.
Patient information at the
time of discharge and
prognosis within 1 year of
discharge was
prospectively collected.
Data were collected up to
December 2016. End
points of this study were
all-cause death and HF
readmission within one
year of discharge. Data
are expressed as mean and
standard deviation for
normally distributed
variables, and as median
with interquartile range
(IQR) for non-normally
distributed data.
Categorical data are
expressed as numbers and
percentages. The KruskalWallis test, chi-square
tests, Kaplan-Meier

The prescription of
GDMT before
discharge was
significantly
associated with a
lower 1-year
mortality. Patients
on both ACE-I/ARB
and BB at discharge
showed more
favorable 1-year
survival than
patients on either
ACE-I/ARB or BB.
GDMT was not
associated with a
lower HF
readmission rate
when accounting for
death as a competing
risk

Results imply that the hospitalization
is an important time to optimize HF
medication for patients with HF.
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Fonarow et
al., 2012.

Level III
Grade A

What are the
individual and
incremental
benefits of
guideline‐
recommended
HF therapies
associated with
24‐month
survival?

None

Patients with a clinical
diagnosis of HF or
prior myocardial
infarction documented
on at least 2 separate
visits were eligible for
enrollment. Reduced
LVEF was required to
be demonstrated by a
quantitative LVEF
≤35% or by qualitative
findings of moderate to
severe left ventricular
systolic dysfunction.
Patients with a noncardiovascular medical
condition with an
estimated survival of
<1 year and those who
had undergone cardiac
transplantation were
excluded.

Basoor et
al., 2013.

Level I
Grade A

Is using a simple
checklist for HF
associated with
better quality of
care and
decreased
readmission for
HF patients?

None

The selection of
patients for use of the
checklist was the
decision of the
attending physician or
house staff or nurse
practitioner taking care
of the patient and was
encouraged but not
enforced to be used for
all HF patients.
Inclusion criteria
included patients
admitted with a
primary diagnosis of

estimates, log-rank test,
Gray test, the Cox
regression model, and the
Hosmer-Lemeshow test
were all used. Statistical
analyses were performed
using R version 3.1.2.
Data were collected by
medical chart review. A
logistic regression model
was used. Descriptive
summary statistics of
baseline patient and
practice characteristics
were calculated for the
case and control groups
and both groups
combined. Continuous
variables were analyzed
using the 2‐sample t test,
and categorical variables
were analyzed with the
chi‐square test. The
unadjusted odds ratio
(OR) of death was
determined using a
logistic regression model
with the therapy as the
predictor variable and no
covariate adjustment.
Analyses were completed
with SAS statistical
software, version 9.1.
Continuous variables are
presented as mean
standard deviation and
categorical variables as
frequencies and
percentages. Unpaired
Student t test was used to
compare continuous
variables. Test for two
proportions and chisquare test were used to
compare categorical
variables. Fisher exact test
was used instead if any
one value in the

Individual and
incremental use of
guideline‐
recommended
therapies was
associated with
survival benefit,
with a potential
plateau at 4 to 5
therapies. There was
an incremental
benefit with each
successive
guideline‐
recommended
therapy.

Provides further rationale to
implement guideline‐recommended
HF therapies in the absence of
contraindications to patients with HF
and reduced left ventricular ejection
fraction.

The study
demonstrates a
decrease in 30-day
and 6-month
readmission rates for
HF patients with the
use of the checklist.

Use of a checklist may have a
signiﬁcant impact in enhancing quality
of care, improving clinical outcomes,
and, in turn, decreasing the burden on
the health care system.
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Deschaseaux Level III
et al., 2016. Grade B

What is the
treatment
initiation patterns
among newly
diagnosed HF
patients in the
United States,
subsequent
treatment
modifications,
hospitalizations
and the impact of
hospitalizations
on therapy
changes, and
treatment
adherence and
persistence?

None

acute decompensated
HF from August 2008
to October 2009.
Exclusion criteria
included pregnancy
and patients younger
than18 years.
Data came from the
administrative claims
of the Truven Health
Market Scan
Commercial Claims
and Encounters
(CCAE) database and
the Medicare
Supplemental and
Coordination of
Benefits database.
Adult patients (>18
years of age) with at
least 2 medical claims
within 12 months on
different dates
corresponding to a HF
diagnosis during the
period from April 1,
2009, to March 31,
2012, were identified.
Patients were required
to have continuous
enrollment in the
database for 1 year
before the diagnosis of
congestive HF and at
least 1 year of followup data after the index
date. To ensure that
prevalent patients were
not included, patients
with HF diagnosis in
the 12 months preindex period were
excluded. Patients with
multiple comorbidities
were not excluded.

calculation was <5.
Statistical tests were
derived from Mini Tab
15.3, version 8.

Data were summarized
using descriptive
analyses. For categorical
variables, counts and
percentages were
provided for each
treatment class. No testing
information provided.

More than one third
of newly diagnosed
HF patients do not
receive HF-specific
medication within
30 days following
initial diagnosis.
More than 60% of
patients continued
on the same therapy
after all-cause or
HF-related
hospitalization.

We need to understand the reasons for
the demonstrated delay in HF
treatment initiation and limited use of
guideline-directed medical therapy
after initial diagnosis.
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Legend:
AA- Aldosterone antagonist
ACEi/ARB- Angiotensin-converting enzyme inhibitors/Angiotensin II receptor blockers
AMI-Acute myocardial infarction
BB-Beta blocker
CMS-Centers for Medicare and Medicaid Services
ESRD-End-stage renal disease
HF-Heart failure
HfrEF-Heart failure with reduced ejection fraction
GDMT-Guideline directed medical therapy
GWTG- Get With The Guidelines
SAS-Statistical analysis software
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Appendix D
Table 1
Synthesis Table
Themes
Articles

Variability in treatment of
HF patients

Kociol et al.,
2012

Hospitals varied significantly
with processes of care used;
Use of computerized
reminders and discharge
checklists to improve
adherence to evidence-based
therapies used in <50% of
sites surveyed.
Clinicians frequently deviate
from guidelines at both
academic and community
hospitals

Gilstrap et
al., 2018

Bergethon et
al., 2016

Improvement of
mortality

Effect on readmission

Only processes in the
discharge and
transitional care domain
had even a modest
association with lower
readmission rate.

Renal dysfunction leading to
readmission
.

Renal dysfunction was the
most common reason for
discharge with congestion, and
hypotension the most common
reason for discharge with no or
decreased neurohormonal
therapy.
Teaching hospitals >
relative readmission rates
compared with
nonteaching hospitals;
1.4% of hospitals
examined in this study
achieved a 20%
reduction in relative 30day readmission rates;
hospitals that used post
discharge heart failure
disease management
programs had lower
relative readmission
rates.

Leadership involvement and further
research for performance and quality
improvement for HF.
Results suggest a need for better evidence and
resources dedicated to effectively achieve
lower readmission rates.
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Wang et al.,
2011

Heidenreich
et al., 2014

Cutshall et
al., 2018

Yamaguchi
et al., 2018

Fonarow et
al., 2012

Hospitals with excellent
performance to both
AMI and HF processes
had significantly longer
duration of GWTG
participation and less inhospital mortality

The use of several treatments
remained low, including use
of hydralazine–nitrate
combination for patients of
African descent and
aldosterone antagonists in
appropriate candidates.
Most patients with ESRD and
HfrEF were not receiving
GDMT

83.7% of patients receiving
BB at discharge, whereas
72.5% of patients receiving
ACE-I/ARB at discharge

Public reporting of hospital quality may have
a greater impact than recognition of top
hospitals because of stigma. Joint
Commission and CMS have measured and
publicly reported hospital quality of care for
more than 10 years.
Shorter LOS in the
GDMT group may be
clinically significant

Optimization of GDMT
before discharge was
associated with a lower
1-year mortality in
patients hospitalized with
HfrEF
Strong associations
between β‐blocker and
ACEI/ARB use and
improved survival.
Individual, and
incremental use of
GDMT therapies was
associated with survival
benefit

Carvedilol remains a preferred
agent in this
patient population, which was
also observed in our study
based on the prescribed home
medications.

Data may provide further rationale for using
systems, performance improvement, and
disease management programs to ensure the
implementation of guideline‐recommended
HF therapies into clinical practice.
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Basoor et
al., 2013

Use of the HF checklist
resulted in increased use of
ACE inhibitors/ARBs at
discharge.

Deschaseaux
et al., 2016

Approximately 42% of
patients not prescribed HFspecific treatment within 30
days .1/3 of newly diagnosed
HF patients do not receive
HF-specific medication
within 30 days following
initial diagnosis.

This checklist may have
a signiﬁcant impact in
enhancing quality of
care, improving clinical
outcomes, and, in turn,
decreasing the burden on
the health care system

The use of an HF
checklist was associated
with better quality of
care and decreased
readmission rates for
patients admitted with
HF

Large-scale quality-improvement projects are
needed to further validate the effects of a HF
checklist

Need for further research to better understand
the reasons for the demonstrated delay in HF
treatment initiation and limited use of
guideline-directed medical therapy after initial
diagnosis.
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Appendix E
Table 1
Project Schedule

ID practice problem,
review literature, and
appraise.
Review prospective
project plan and literature
results with preceptor and
Update supportive
evidence table
ID Key stakeholders and
team members with
preceptor
Speak with key
stakeholders and obtain
executive support
ID action plan, potential
budget, and prospective
time line with preceptor.
Review evaluation and
dissemination plan.
Complete IHI
Improvement Capability
Self-Assessment Tool
and identify and discuss
gap for needed
organizational process
change
ID possible limitations,
goals and milestones with
preceptor. Identify HER
capability for project
timeline.
Finalize project proposal
Examine IRB protocols
with preceptor
ID Metrics from the
measures identified from
the internal data and set

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7803

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7802

Week 5

Week 3

Week 1

Activity

NUR7801
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performance measures
Create Project Charter
Create Project Scope
Statement
Review Charter and
Scope Statement with
preceptor
Send invites to initial
meeting with key
stakeholders and plan
agenda with presentation
materials.
Present Project to
Stakeholders, confirm
budget, discuss project
plan, and participate in
the Failure Modes and
Effect Analysis (FMEA)
and assess for project
sustainability
Educate CVU staff on
discharge protocol
process and potential
benefits to patient
outcomes.
Initiate protocol on
inpatient unit
Evaluate adherence to
protocol, project data and
enter into evaluation
software.
Update key stakeholders
on progress of project
Collect project data and
enter into evaluation
software
Meet with Director of IS
to ensure correct data
evaluation methods.
Finalize project data
collection period and
enter all data. Begin
scholarly project report.
Conduct statistical
analysis to evaluate
reliability and feasibility
of results.

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7803

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7802

Week 5

Week 3

Week 1

Activity

NUR7801
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Complete scholarly
project report and prepare
presentation of results.
Submit project to editor.
Invite key stakeholders to
presentation of results.
Finalize DNP scholarly
project and present
results to key
stakeholders.
Evaluate process of
project with preceptor
and areas for
improvement
Plan for submission to
journals and conferences

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7803

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7802

Week 5

Week 3

Week 1

Activity

NUR7801
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Appendix F
Figure 1
S.W.O.T Analysis
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Appendix G
Table 1
Benchmarking Measures Data
Objective
Outcome

Process

Balancing

Financial

Sustainability

Initiative
Reduce 30-day
readmission
rates of patients
with HF
HF Discharge
protocol
utilization

Having charge
nurse identify
HF patients and
remind
practitioner in
daily rounding
about ordering
protocol at
discharge

Reduce
readmission
cost for HF
patients
HF Discharge
protocol
utilization post
project
conclusion

Measure

Target

Responsible
Party

Reporting
Frequency

Benchmark

30-day
readmission
rate

>20%
reduction

How many
times protocol
used/How
many HF
patients
discharged
How many HF
patients were
identified?

Results

Project manager

Every 30
days after
project start

45%

30 days

>95%

Project manager

Every week

33%

1

>95%
of HF
patients

Project manager

Every 2
weeks

20

1st 2 weeks

2nd 2 weeks

3rd 2 weeks

4th 2 weeks

How many
times did they
mention
protocol in
rounding?

>100%

Project manager

Every 2
weeks

0

1st 2 weeks

2nd 2 weeks

3rd 2 weeks

4th 2 weeks

Cost of
readmission

>20%
reduction

Project manager

Every 30
days after
project start

$146,310.00

30 days

How many
times protocol
used/How
many HF
patients
discharged

>95%
utilization

Project manager

Once

33%

30 days post project completion date

2

60 days

3

4

5

6

60 days

90 days

7

8

9

10

11

90 days

12

13
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Appendix H
Table H1.
Frequencies for 30-day Readmission Rate

Table H2.
Chi-square Test

Table H3.
Two-Tailed Paired Samples t-Test

65
Table H4.
Process Measure

66
Figure H1.
Run Chart of How Many Time Protocol Was Used
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Table H5.
Number of Times Protocol Mentioned in Rounding to Physicians

Table H6.
Financial Measure

68
Figure H2.
Bar Plot of Protocol Usage in Trimester 3
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Appendix I
Figure I1.
Approval email to use Iowa Model
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Figure I2.
Approval to Use Johns Hopkins Nursing Evidence-Based Practice Model and Tools

71
Figure I3.
Letter of Approval from American Heart Association

